Navigation Links
Parkinson's Linked to Risk of Alzheimer's
Date:10/8/2007

Relatives of Parkinson's patients more likely to develop dementia, study finds

MONDAY, Oct. 8 (HealthDay News) -- Relatives of people with Parkinson's disease face up to a 73 percent increased risk for developing Alzheimer's disease, suggests a new study that says genetics could be to blame.

Parkinson's disease causes declines in functions of the central nervous system, such as impaired motor skills and speech.

"The co-occurrence of Alzheimer's disease and Parkinson's disease in families and in individuals may be due to the sharing of susceptibility genetic variants," according to the report in the October issue of the Archives of Neurology.

In the study, Dr. Walter A. Rocca, of the Mayo Clinic College of Medicine in Rochester, Minn., and colleagues collected data on 1,019 first-degree relatives of 162 patients with Parkinson's disease, and on 858 relatives of 147 people who were the same age and sex as someone in the Parkinson's disease group but did not have the condition. Also included were 2,716 relatives of 411 patients with Parkinson's disease who were referred to the Mayo Clinic.

The researchers found that relatives of those with Parkinson's had a 37 percent increased risk of developing Alzheimer's, compared to those with relatives who didn't have the disease. Moreover, relatives of people who developed Parkinson's before the age of 66 were 73 percent more likely to develop Alzheimer's, the study found.

"We studied brothers, sisters, parents and children of patients with Parkinson's diseases and looked at how many developed dementia or cognitive impairment," said study co-author Dr. James H. Bower, also of the Mayo Clinic. "We found that if you had a first-degree relative with Parkinson's disease, you are more likely to develop cognitive impairment or dementia than if you didn't have a first-degree relative with Parkinson's disease.

"These are different diseases," Bower said, "but there looks to be some shared risk factors for both diseases. We don't know what these shared risk factors are. One could be genetic, but it could be environmental. We have to start looking at neurodegenerative diseases as having a common mechanism. If we could find the cause of one, it could lead to cures and understanding of others."

One expert sees a potential connection between a mechanism at work in both diseases.

"This study provides strong evidence for some increase in risk for cognitive decline and dementia in relatives of Parkinson's disease victims," said Greg M. Cole, a neuroscientist at the Greater Los Angeles VA Healthcare System and the associate director of the Alzheimer's Disease Research Center at UCLA's David Geffen School of Medicine. "The authors conclude with the logical inference that Parkinson and Alzheimer diseases share some genetic or environmental risk factors."

Likely common risk factors for both diseases could be oxidative damage and inflammation, Cole said.

More information

To learn more about Parkinson's disease, visit the U.S. National Institute of Neurological Disorders and Stroke.



SOURCES: James H. Bower, M.D., Mayo Clinic, Rochester, Minn.; Greg M. Cole, Ph.D., neuroscientist, Greater Los Angeles VA Healthcare System, and associate director, Alzheimer's Disease Research Center, UCLA David Geffen School of Medicine, Los Angeles; October 2007, Archives of Neurology


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Gambling related to Parkinsons medication
2. Drug Pramipexole Usage Linked To Gambling Addiction In Parkinsons Patients
3. Highly Educated More Prone To Parkinsons Disease
4. Make Treatment of Parkinsons More Affordable, Doctors Plead
5. Parkinsons Disease can Be Predicted by Metabolic Pathway
6. Neural Stem Cells Reduce Parkinsons Symptoms in Monkeys
7. Risk of Parkinsons Increased by Exposure to Pesticide and Head Trauma
8. Coenzyme Q10 Does Not Improve Parkinsons Disease Symptoms
9. Patients Affected by Parkinsons may Be Benefited from Treadmill Exercise
10. UCLA Researchers Discover Link Between Parkinsons and Narcolepsy
11. First Ever Patch Drug To Treat Parkinsons Symptoms Approved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... Sept. 25, 2017   Montrium , an ... solutions, today—from the IQPC Trial Master Files & ... NL)—announced that EastHORN Clinical Services has selected ... and TMF management. EastHORN, a leading European contract ... to increase transparency to enable greater collaboration with ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology: